Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+7.23%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$39.9B
AUM Growth
+$1.35B
(+3.5%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
2,910
New
490
Increased
855
Reduced
1,229
Closed
318
Top Buys
| 1 |
Tesla
TSLA
|
+$398M |
| 2 |
NVIDIA
NVDA
|
+$370M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$334M |
| 4 |
Pfizer
PFE
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$299M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$408M |
| 3 |
Snap
SNAP
|
+$379M |
| 4 |
Analog Devices
ADI
|
+$283M |
| 5 |
AT&T
T
|
+$279M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 22.87% |
| 3 | Industrials | 9.09% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
WSFS Financial
WSFS
$3.13B
| $316K | ﹤0.01% |
6,300
-1,300
| -17% | -$65.2K |
|
2127
Evolus
EOLS
$465M
| $315K | ﹤0.01% |
48,400
-33,200
| -41% | -$216K |
|
2128
Riverview Bancorp
RVSB
$102M
| $315K | ﹤0.01% |
40,900
-900
| -2% | -$6.93K |
|
|
GOL
2129
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $313K | ﹤0.01% |
51,771
-136,200
| -72% | -$823K |
|
2130
WPP
WPP
$5.86B
| $310K | ﹤0.01% |
4,100
-5,500
| -57% | -$416K |
|
|
ZYNE
2131
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $310K | ﹤0.01% |
107,500
-67,800
| -39% | -$196K |
|
2132
GXO Logistics
GXO
$5.84B
| $309K | ﹤0.01% |
3,400
-10,000
| -75% | -$909K |
|
|
MSB
2133
Mesabi Trust
MSB
$412M
| $309K | ﹤0.01% |
11,700
+1,516
| +15% | +$40K |
|
2134
Tonix Pharmaceuticals
TNXP
$251M
| $307K | ﹤0.01% |
+1
| New | +$307K |
|
2135
EQT Corp
EQT
$31.8B
| $305K | ﹤0.01% |
+14,000
| New | +$305K |
|
2136
Mistras Group
MG
$299M
| $305K | ﹤0.01% |
41,024
+9,800
| +31% | +$72.9K |
|
2137
Confluent
CFLT
$6.63B
| $305K | ﹤0.01% |
+4,000
| New | +$305K |
|
2138
Larimar Therapeutics
LRMR
$336M
| $304K | ﹤0.01% |
28,198
-4,700
| -14% | -$50.7K |
|
2139
Zevra Therapeutics
ZVRA
$435M
| $303K | ﹤0.01% |
34,800
+10,500
| +43% | +$91.4K |
|
2140
MarineMax
HZO
$556M
| $301K | ﹤0.01% |
+5,100
| New | +$301K |
|
2141
Tompkins Financial
TMP
$1B
| $301K | ﹤0.01% |
+3,600
| New | +$301K |
|
|
CNCE
2142
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $301K | ﹤0.01% |
95,400
+45,900
| +93% | +$145K |
|
|
ITI
2143
DELISTED
Iteris, Inc.
ITI
| $299K | ﹤0.01% |
74,800
+23,800
| +47% | +$95.1K |
|
2144
BayCom
BCML
$324M
| $298K | ﹤0.01% |
15,900
-8,400
| -35% | -$157K |
|
2145
Orthofix Medical
OFIX
$589M
| $298K | ﹤0.01% |
9,600
+2,426
| +34% | +$75.3K |
|
|
ALLK
2146
DELISTED
Allakos
ALLK
| $296K | ﹤0.01% |
30,200
-5,200
| -15% | -$51K |
|
2147
Cabaletta Bio
CABA
$168M
| $296K | ﹤0.01% |
78,100
+38,000
| +95% | +$144K |
|
|
SYRS
2148
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $295K | ﹤0.01% |
9,060
-8,210
| -48% | -$267K |
|
2149
Ligand Pharmaceuticals
LGND
$3.23B
| $293K | ﹤0.01% |
+3,046
| New | +$293K |
|
2150
Ultra Clean Holdings
UCTT
$1.14B
| $293K | ﹤0.01% |
5,100
-28,800
| -85% | -$1.65M |
|